Salvatore Lucio Cutuli, Elena Sancho Ferrando, Fabiola Cammarota, Emanuele Franchini, Alessandro Caroli, Gianmarco Lombardi, Eloisa Sofia Tanzarella, Domenico Luca Grieco, Massimo Antonelli, Gennaro De Pascale
{"title":"维生素 D 在严重感染和败血症中的最新作用。","authors":"Salvatore Lucio Cutuli, Elena Sancho Ferrando, Fabiola Cammarota, Emanuele Franchini, Alessandro Caroli, Gianmarco Lombardi, Eloisa Sofia Tanzarella, Domenico Luca Grieco, Massimo Antonelli, Gennaro De Pascale","doi":"10.1186/s44158-024-00139-5","DOIUrl":null,"url":null,"abstract":"<p><p>Severe infections frequently require admission to the intensive care unit and cause life-threatening complications in critically ill patients. In this setting, severe infections are acknowledged as prerequisites for the development of sepsis, whose pathophysiology implies a dysregulated host response to pathogens, leading to disability and mortality worldwide.Vitamin D is a secosteroid hormone that plays a pivotal role to maintain immune system homeostasis, which is of paramount importance to resolve infection and modulate the burden of sepsis. Specifically, vitamin D deficiency has been widely reported in critically ill patients and represents a risk factor for the development of severe infections, sepsis and worse clinical outcomes. Several studies have demonstrated the feasibility, safety and effectiveness of vitamin D supplementation strategies to improve vitamin D body content, but conflictual results support its benefit in general populations of critically ill patients. In contrast, small randomised clinical trials reported that vitamin D supplementation may improve host-defence to pathogen invasion via the production of cathelicidin and specific cytokines. Nonetheless, no large scale investigations have been designed to specifically assess the impact of vitamin D supplementation on the outcome of critically ill septic patients admitted to the intensive care unit.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":"4 1","pages":"4"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10804708/pdf/","citationCount":"0","resultStr":"{\"title\":\"Update on vitamin D role in severe infections and sepsis.\",\"authors\":\"Salvatore Lucio Cutuli, Elena Sancho Ferrando, Fabiola Cammarota, Emanuele Franchini, Alessandro Caroli, Gianmarco Lombardi, Eloisa Sofia Tanzarella, Domenico Luca Grieco, Massimo Antonelli, Gennaro De Pascale\",\"doi\":\"10.1186/s44158-024-00139-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Severe infections frequently require admission to the intensive care unit and cause life-threatening complications in critically ill patients. In this setting, severe infections are acknowledged as prerequisites for the development of sepsis, whose pathophysiology implies a dysregulated host response to pathogens, leading to disability and mortality worldwide.Vitamin D is a secosteroid hormone that plays a pivotal role to maintain immune system homeostasis, which is of paramount importance to resolve infection and modulate the burden of sepsis. Specifically, vitamin D deficiency has been widely reported in critically ill patients and represents a risk factor for the development of severe infections, sepsis and worse clinical outcomes. Several studies have demonstrated the feasibility, safety and effectiveness of vitamin D supplementation strategies to improve vitamin D body content, but conflictual results support its benefit in general populations of critically ill patients. In contrast, small randomised clinical trials reported that vitamin D supplementation may improve host-defence to pathogen invasion via the production of cathelicidin and specific cytokines. Nonetheless, no large scale investigations have been designed to specifically assess the impact of vitamin D supplementation on the outcome of critically ill septic patients admitted to the intensive care unit.</p>\",\"PeriodicalId\":73597,\"journal\":{\"name\":\"Journal of Anesthesia, Analgesia and Critical Care (Online)\",\"volume\":\"4 1\",\"pages\":\"4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10804708/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Anesthesia, Analgesia and Critical Care (Online)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s44158-024-00139-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Anesthesia, Analgesia and Critical Care (Online)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s44158-024-00139-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
严重感染常常需要入住重症监护室,并导致危重病人出现危及生命的并发症。维生素 D 是一种类固醇激素,在维持免疫系统平衡方面发挥着关键作用,而免疫系统平衡对于解决感染和减轻败血症负担至关重要。具体而言,维生素 D 缺乏症已在重症患者中被广泛报道,它是导致严重感染、败血症和临床预后恶化的一个风险因素。有几项研究已经证明了维生素 D 补充策略的可行性、安全性和有效性,以提高体内维生素 D 的含量,但对于维生素 D 在危重病人中的益处,研究结果并不一致。相反,小型随机临床试验报告称,补充维生素 D 可通过产生白细胞介素和特定细胞因子,提高宿主对病原体入侵的防御能力。然而,目前还没有大规模的研究专门评估维生素 D 补充剂对重症监护室收治的脓毒症重症患者的预后的影响。
Update on vitamin D role in severe infections and sepsis.
Severe infections frequently require admission to the intensive care unit and cause life-threatening complications in critically ill patients. In this setting, severe infections are acknowledged as prerequisites for the development of sepsis, whose pathophysiology implies a dysregulated host response to pathogens, leading to disability and mortality worldwide.Vitamin D is a secosteroid hormone that plays a pivotal role to maintain immune system homeostasis, which is of paramount importance to resolve infection and modulate the burden of sepsis. Specifically, vitamin D deficiency has been widely reported in critically ill patients and represents a risk factor for the development of severe infections, sepsis and worse clinical outcomes. Several studies have demonstrated the feasibility, safety and effectiveness of vitamin D supplementation strategies to improve vitamin D body content, but conflictual results support its benefit in general populations of critically ill patients. In contrast, small randomised clinical trials reported that vitamin D supplementation may improve host-defence to pathogen invasion via the production of cathelicidin and specific cytokines. Nonetheless, no large scale investigations have been designed to specifically assess the impact of vitamin D supplementation on the outcome of critically ill septic patients admitted to the intensive care unit.